| Website | srone.com |
| Phone | 610.567.1000 |
| Employees | |
| Founded | 1985 |
| Description | Venture Capital |
SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested approximately $600 million in more than 130 companies. For more information please visit www.srone.com
| Company | Date | Round | Size | Participants |
| Trinity Biosystems | 11/09 | Unattributed | $7.5M | 5 |
| Aileron Therapeutics | 6/09 | Series D | $40M | 6 |
| Anaphore | 6/09 | Series A | $13M | 5 |
| CalciMedica | 1/09 | Series C | $4M | 3 |
| POINT Biomedical | 1/08 | Series E | $25M | 5 |